Skip to main content
OpenTrials

Clinical trial condition

Stage III Multiple Myeloma

Explore clinical trials studying Stage III Multiple Myeloma. Study availability and eligibility vary by location and protocol.

49 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Stage III Multiple Myeloma trial results

Completed

Melphalan and Amifostine Followed By One or Two Autologous or Syngeneic Stem Cell Transplants and Maintenance Therapy in Treating Patients With Stage II-III Multiple Myeloma

NCT00217438

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of Rochester Rochester, New York, United States
  • VA Puget Sound Health Care System Seattle, Washington, United States
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details

Related conditions